Decoy Therapeutics

Company snapshot

Decoy Therapeutics is a pharma organization headquartered in HOUSTON, TX, USA. It trades on NYSE under ticker DCOY. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 6 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 6 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Decoy Therapeutics. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Decoy Therapeutics.

1. Feb 18, 2025 Patent grant

   Methods and compositions for treating infections

2. Oct 19, 2021 Patent grant

   Methods of treatment of infections using bacteria

3. Jun 29, 2021 Patent grant

   Compositions and methods for treatment of cancer using bacteria

4. Feb 5, 2019 Patent grant

   Compositions and methods for treatment of cancer using bacteria

5. Aug 21, 2018 Patent grant

   Compositions and methods for treatment of cancer using bacteria

View all clinical trial activity →

• What is Decoy Therapeutics?

  Decoy Therapeutics is a pharma organization headquartered in HOUSTON, TX, USA. It trades on NYSE under ticker DCOY. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 6 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• Is Decoy Therapeutics publicly traded?

  Yes. Decoy Therapeutics is listed with ticker DCOY on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Decoy Therapeutics develop or market?

  No drug profiles are currently linked to Decoy Therapeutics. Pipeline programs may still list investigational assets.

• What are the latest developments for Decoy Therapeutics?

  Browse related news and pipeline sections on this page for coverage and ClinicalTrials.gov-linked program updates.

• What therapeutic areas does Decoy Therapeutics focus on?

  No specific therapeutic focus areas are currently identified for Decoy Therapeutics in our database.